Professor Denise Patricia Mawili Mboumba

Background

Denise Patricia Mawili Mboumba is Full Professor in Parasitology at the Université des Sciences de la Santé in Gabon. She earned her PhD at Eberhard Karls University of Tübingen, in Germany. She continued her research activities in Gabon, where she currently serves as the head of the Research Unit on Infectious Agents and their Pathology, and Director of the Institute of Medical Biology at the Université des Sciences de la Santé in Gabon. She is also coordinator of the Master of Science on Infectious pathogens option Medical Parasitology-Mycology.

Research

For over 15 years, she has conducted her research activities in the Department of Parasitology-Mycology within the Faculty of Medicine, focusing on parasitic diseases endemic to Gabon, notably Malaria (epidemiology, genetic diversity, drug resistance), Filariasis and Intestinal Parasitic infections. She is author and co-author of over 60 publications and successfully supervised numerous students including MD, PharmD, MSc and PhD students.

As AfOx Fellow, her work is focused on Implementation of a Laboratory Quality Management System (LQMS) in the Department of Parasitology-Mycology-Tropical Medicine (DPMMT) in Libreville, Gabon with the support of the Infectious Diseases Data Observatory (IDDO) at the University of Oxford. Her placement will enable her to observe best practice laboratory setup and management in a reference laboratory.

Publications

https://pubmed.ncbi.nlm.nih.gov/?term=mawili+mboumba&sort=date

Selected publications

1- Spatio-temporal heterogeneity of urban malaria in Libreville, Gabon (2012-2023): neighborhood-level hotspot analysis for micro-stratified control. Malar J. 2026 Mar 19. doi: 10.1186/s12936-026-05865-5. Online ahead of print.PMID: 41851785.

2- Molecular evidence of co-circulation of different dengue virus serotypes associated with malaria co-infection among febrile children in Libreville, Gabon. . Int J Infect Dis. 2026 May;166:108497. doi: 10.1016/j.ijid.2026.108497. Epub 2026 Feb 19.PMID: 41722758 

3- Assessment of the efficacy and safety of two albendazole regimens for the treatment of hypermicrofilaraemic loiasis in adults in Woleu-Ntem Province, Gabon: A phase IIb single-blind randomised controlled trial. PLoS Negl Trop Dis. 2026 Jan 20;20(1):e0013166. doi: 10.1371/journal.pntd.0013166. eCollection 2026 Jan.

4- Hospital attendance, malaria prevalence and self-medication with an antimalarial drug before and after the start of COVID-19 pandemic in a sentinel site for malaria surveillance in Gabon. Malar J. 2025 Jan 25;24(1):28. doi: 10.1186/s12936-025-05272-2.

5- Efficacy and safety of albendazole 400 mg for 30 days compared to single dose of ivermectin in adult patients with low Loa loa microfilaremia: A non-inferiority randomized controlled trial. PLoS Negl Trop Dis. 2025 Jun 20;19(6):e0012383. doi: 10.1371/journal.pntd.0012383. eCollection 2025 Jun.